GlassScriptPhysician profile
Priti Amin
NPI 1770561482
$1,526.97
in general payments reported to CMS, 2019-2025
30 companies · $333 in 2025
The $333 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.87 · 2022: $294 · 2023: $471 · 2024: $353 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $162.72 | 2024-2025 | Vaxelis, Vaxneuvance, Capvaxive |
| Supernus Pharmaceuticals, INC. | $152.00 | 2022-2024 | Qelbree, Qelbree |
| Janssen Pharmaceuticals, INC | $131.55 | 2021-2023 | Xarelto, Spravato |
| Sanofi Pasteur INC. | $101.99 | 2022-2025 | |
| Glaxosmithkline, LLC. | $84.97 | 2022-2024 | Shingrix, Bexsero, Arexvy |
| Exact Sciences Corporation | $72.95 | 2023-2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $69.32 | 2021-2024 | Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $64.02 | 2022 | |
| Lilly USA, LLC | $58.24 | 2023 | Jardiance, Baqsimi, Emgality |
| Amgen INC. | $57.15 | 2022-2023 | Prolia, Evenity |
| Ars Pharmaceuticals Operations, INC. | $51.12 | 2025 | Neffy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.64 | 2024 | Xifaxan |
| Dynavax Technologies Corporation | $45.84 | 2024 | Heplisav-B |
| Kaleo, INC. | $44.53 | 2022-2023 | Auvi-Q |
| Dexcom, INC. | $38.62 | 2025 | Dexcom G6 Transmitter |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $38.32 | 2025 | Jornay Pm |
| Cranial Technologies, INC | $34.78 | 2024 | Doc Band |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.39 | 2023-2024 | |
| Currax Pharmaceuticals LLC | $29.96 | 2024 | Contrave, Onzetra Xsail |
| Kyowa Kirin, INC. | $26.10 | 2025 | |
| Corium, LLC | $25.54 | 2023 | Azstarys |
| Biohaven Pharmaceuticals, INC. | $23.96 | 2021 | |
| Amarin Pharma, INC. | $20.78 | 2022 | |
| Idorsia Pharmaceuticals US INC | $19.11 | 2022 | |
| Ibsa Pharma INC. | $17.43 | 2022 | |
| Pfizer INC. | $17.35 | 2021 | |
| Almatica Pharma LLC | $15.66 | 2023 | Loreev Xr |
| Astrazeneca Pharmaceuticals LP | $14.46 | 2024 | Airsupra |
| Kowa Pharmaceuticals America, INC. | $14.08 | 2025 | Zoryve |
| Si-Bone, INC. | $13.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priti Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.